Fund your studies with confidence, knowing enrollment is planned and monitored in real time.
We at TrialConX bring all your recruitment vendors, sites and patient events onto a single platform, and grow your network with you, so we can help you plan and execute every study, and reward the partners who deliver. We reward them on real performance, and keep them ahead of what is coming down your pipeline, so they are always ready to adapt their capacity and deliver.
Recruitment and retention are among the largest controllable line items in your trial,1 and the least visible.
Vendors are paid for leads, not results.
Recruitment vendors are paid per referral, not for how many qualify, enroll and stay. They focus on sending more referrals, even when few become enrolled participants. You end up paying for volume that doesn't convert.
Sites are paid too slowly to stay focused.
Nearly 80% of sites hold less than six months of operating capital. 10% hold less than one month, which puts them one late payment from exiting the industry. When cash is that tight, sites prioritize the work that pays faster.2
The data arrives too late to act on.
By the time reporting shows what worked, the budget's spent and the timeline's already slipped.
The real issue is not intent. It's the gaps between organizations.
Everyone wants participants enrolled. The problem is structural: separate systems, no shared performance view, payments that don't reward the right actions fast enough.

We build your network for you.
We load your historic site and vendor data, then assemble and rank a network of sites and vendors matched to your protocol, against your active and planned pipeline. It is proven on real performance, and it compounds study after study.
We measure every participant journey for you.
We track every participant journey end to end, and work with your sites to make sure everything is connected and feeding back live. So you always have the enrollment data to make budget and timeline decisions with confidence.


We make sure your partners are paid on time.
Fast, milestone-based payment — referral, pre-screening, enrollment, first dose — is the single biggest thing that keeps a network engaged on your study. We handle it for you, so partners stay focused instead of chasing cash.
One CRM across every study.
Ask questions in plain English, across your whole portfolio, and act on the answer in one click.

Attribution from spend all the way to a participant who completes the study.
TrialConX sits across all your studies at once, combining deep integrations with the stack you already have, hands-on site engagement, and our own data models. Every participant journey is measured from first dollar spent to last participant, last visit, and the chance to keep each participant engaged is shared with your sites in real time. Every lesson compounds into your next study, so the network keeps learning.
Works with the stack you or your sites already have: RealTime, Advarra, Veeva, CRIO, EDC.
Run a Spend DiagnosticThe whole platform
See everything the platform can do.
You have seen why this matters to you. The platform overview walks through every key feature, from the first referral to enrollment, retention and payment.
Explore the platformHow it works
From kickoff to enrolled participants in three steps.
Scope
We map your pipeline and existing network, identify the gaps, and build a feasibility plan before the study goes live. You see exactly which sites and vendors are matched to your protocol and why, grounded in real performance data.
Launch
We activate your sites and vendors on the platform, connect to their existing tools, and start tracking every participant from the first referral. Live funnel data and milestone-based payment rails are in place from day one.
Optimize and pay
We surface what is working and what is not in real time, so you can redirect budget before the timeline slips. Partners are rewarded on milestone, so the network stays motivated for the full duration of your study.
We all do well when participants enroll.
Do you know which sites and vendors will deliver on your active studies, let alone your next ones? Can you see where participants are most likely to miss their next visit, before they do? If not, that is exactly the gap we close.
¹ US federal analysis of negotiated trial contracts puts patient recruitment, patient retention, site recruitment and site retention at a combined 18 to 20% of per-study costs in Phases II to IV (ASPE, 2014).² SCRS 2023 Site Landscape Survey, approximately 550 site respondents. 51% of sites report monthly payment agreements, but sites report not receiving monthly payments. 23% say 31 to 40% of their invoices are already more than 90 days late.